Loading insider details...
Beta
Latest Form 4 (Aug 4, 2026): Grant/Award of 152,353 ELDN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 4, 2026 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 152,353 | n/a |
| Jan 13, 2025 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 243,000 | n/a |
| Nov 22, 2024 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 840,438 | n/a |
| Jun 14, 2024 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 428,148 | n/a |
| May 2, 2023 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 317,147 | n/a |
| Feb 2, 2023 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 155,000 | n/a |
| Nov 23, 2022 | Eledon Pharmaceuticals, Inc. (ELDN) | Purchase | 1,000 | $2.6K |
| Feb 2, 2022 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 155,000 | n/a |